Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorIris, Nur Efe
dc.contributor.authorYildirmak, Taner
dc.contributor.authorGedik, Habip
dc.contributor.authorSimsek, Funda
dc.contributor.authorAydin, Demet
dc.contributor.authorDemirel, Naciye
dc.contributor.authorYokus, Osman
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:56:23Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:56:23Z
dc.date.issued2017
dc.identifier.issn1300-7777
dc.identifier.issn1308-5263
dc.identifier.urihttps://dx.doi.org/10.4274/tjh.2016.0123
dc.identifier.urihttp://hdl.handle.net/11446/2294
dc.descriptionWOS: 000403951100007en_US
dc.descriptionPubMed ID: 27348760en_US
dc.description.abstractObjective: The aim of this study is to investigate if neutrophil CD64 expression in febrile neutropenia patients could be used as an early indicator of bacteremia. Materials and Methods: All consecutive patients older than 18 years of age who had developed febrile neutropenia episodes due to hematological malignancies were included in the study. Those patients who had significant growth in their blood cultures constituted the case group, while those who had febrile neutropenia without any growth in their cultures and who did not have any documented infections formed the control group. Blood culture bottles were incubated in the Bact ALERT 3D system (bioMerieux, France), identification and susceptibility testing were performed using an automated broth microdilution method (VITEK 2, bioMerieux), and CD64 expression analysis was performed by the flow cytometry method. C-reactive protein (CRP) was measured by turbidimetric methods (Biosystems, Spain) and erythrocyte sedimentation rate (ESR) was measured by the Wintrobe method. Results: In total, we prospectively evaluated 31 febrile episodes. The case group consisted of 17 patients while the control group included 14 patients. CD64 was found on neutrophils of the case group patients with a mean count of 8006 molecules/cell and of control group with a mean count of 2786 molecules/cell. CD64 levels of the case group were significantly higher than those of the control group (p=0.005). In the differentiation of the case group from the control group, a 2500 cut-off value for CD64 had significant [AUC=0.792 (0.619-0.965)] predictive value (p=0.001). In the prediction of patients with a 2500 cut-off value for CD64, sensitivity was 94.1%, positive predictive value was 76.2%, specificity was 64.3%, and negative predictive value was 90.0%. CRP levels and ESR values did not differ significantly between the groups (p=0.005). Conclusion: Neutrophil CD64 expression could be a good predictor as an immune parameter with high sensitivity and a negative predictive value for bacteremia in febrile neutropenic patients.en_US
dc.language.isoengen_US
dc.publisherGALENOS YAYINCILIKen_US
dc.identifier.doi10.4274/tjh.2016.0123en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeutrophilen_US
dc.subjectCD64en_US
dc.subjectBacteremiaen_US
dc.subjectFebril neutropeniaen_US
dc.subjectDiagnostic parameteren_US
dc.titleCould Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?en_US
dc.typearticleen_US
dc.relation.journalTURKISH JOURNAL OF HEMATOLOGYen_US
dc.departmentDBÜen_US
dc.identifier.issue2en_US
dc.identifier.volume34en_US
dc.identifier.startpage167en_US
dc.identifier.endpage173en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Iris, Nur Efe] Istanbul Bilim Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Yildirmak, Taner -- Gedik, Habip -- Simsek, Funda] Okmeydani Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Aydin, Demet -- Demirel, Naciye -- Yokus, Osman] Okmeydani Training & Res Hosp, Clin Hematol, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster